After a lull, the Indian clinical trial industry is likely to witness progress, due to a slew of regulatory measures adopted by the overnment. However, a lot needs to be done to position India a clinical trial hubs.
Recent years have seen a slowdown of clinical trials in India in the wake of stringent directives from the Supreme Court asking the government and regulatory agencies to take measures to ensure safety of patients participating in clinical trials of new medicines.
Over the last year and a half, the Ministry of Health and Family Welfare has taken various steps to address the challenges posed by regulatory uncertainty. Regulations were amended and further guidance was given on existing ones.
India accounts 17 per cent of the global population and 20 per cent of the global disease burden but still accounts for a significantly low number of clinical-trials.
Suneela Thatte, President, Indian Society for Clinical Research (ISCR) informs, “For a country that has the second highest population in the world and the highest burden of disease, around 1.4 per cent of global clinical trials takes place in India (https://clinicaltrials. gov/ct2/search/map?map=SS). That in itself is indicative of how under represented India is in terms of clinical research. Besides a high patient population and a significant representation of diseases characteristics of both developing and developed economies, India also has well qualified English speaking investigators and good infrastructure. So, we have all the requisite requirements needed for clinical research.”
However, market reports explain that the situation was not so unfavourable for the Indian clinical research industry till 2010 from between 2004-10, many multinational and domestic pharmaceutical companies choose India as the preferred destination for conducting clinical trials. Then why did the situation turned so bad?
Bu hikaye Express Pharma dergisinin October 16, 2016 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Express Pharma dergisinin October 16, 2016 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
MAKING SUSTAINABILITY SUSTAINABLE
Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, MSME pharma companies need to carefully balance their sustainability goals with financial viability
New energy recovery system for tablet coaters
Upto 50 per cent less steam energy consumption
The future of pharma logistics: Trends, challenges, and opportunities
Nikhil Agarwal, President, CJ Darcl Logistics explains that the future of pharma logistics is a thrilling frontier shaped by technological advancements, regulatory challenges, and the imperative of sustainability. As the industry transforms, logistics providers must embrace innovative solutions and adapt to shifting demands
Achieving Aatmanirbharta In APIs Are We On The Right Track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats
Yokogawa launches OpreX Data Model Broker
A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation
Understanding the nuances of generics injectables
At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial
Trending in nutraceuticals: Science meets sustainability
Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe
The growth of e-pharmacies in India
Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these
Xylitol and Maltitol: Low-calorie sugar alternatives
Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste
Single-use TC gaskets and their importance
Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.